BioPerfectus
Biotechnology Empowers the Perfection of Human Life

Jiangsu Bioperfectus Technologies Co., Ltd.

(SSE:688399)

BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers specialized in infectious diseases ever since 2010. With headquarter located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi’an, Taizhou, Hainan and Yinchuan. Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations.

62,000+㎡

An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios

600+

Over 600 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic

5,000,000+

Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases

global presence

80 Countries within a year

Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.

10000 Machinery spots

Bioperfectus Nucleic Acid Extraction Solutions 
were launched in over 10,000 laboratories 
globally with a well-trained and quick-response 
customer service team.

News Center
01-282022
Bioperfectus COVID-19 Antigen Self-Testing is now officially included in Austrian Certified Listing
Bioperfectus COVID-19 Antigen Self-Testing is now officially included in Austrian Certified Listing
01-282022
Another piece of good news! BioperfectusNovel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test) is now officially included in Austrian Certified SARS-CoV-2 Antigen Rapid Tests Listing. Click here to learn more.
01-272022
Bioperfectus Mass Distribution of Rapid COVID-19 Tests in Israel Begins
Bioperfectus Mass Distribution of Rapid COVID-19 Tests in Israel Begins
01-272022
The demand for rapid tests is expected to go up after the government announced that the mandatory quarantine period for Israelis infected with COVID-19 would be shortened from a week to five days on January 17th, 2022. According to Israels Health Ministry, a negative home antigen test is also required before ending isolation. Prime Minister Naftali Bennett said a spike in infections due to the Omicron variant of the coronavirus and the number of people in isolation has become a burden on the ...
01-242022
Cervical Cancer Awareness Month 2022
Cervical Cancer Awareness Month 2022
01-242022
January is Cervical Cancer Awareness month. Together we can raise the awareness of cervical cancer and cure the disease that is curable and preventable. What Is Cervical Cancer? Cervical cancer starts in the cells lining the cervix -- the lower part of the uterus (womb). The cervix connects the body of the uterus (the upper part where a fetus grows) to the vagina (birth canal). The cervix is made of two parts and is covered with two different types of cells. The endocervix is the o...
Service Network
Support is only one step away
A good after-sales service is essential for efficiency of workload in PCR laboratory. Bioperfectus delivers most perfect service via our authorized distributors and global service center. With well-experienced service staff, sufficient spare-part inventory and fast global logistics, Bioperfectus aims to provide with the satisfactory solutions to our end users.We offer 24/7 after-sales service, prompt response and periodical training programs.
CONTACT US NOW